Physician profile
Hazen H Tuck
NPI 1124225487
$6,601.45
in general payments reported to CMS, 2019-2025
19 companies · $31.56 in 2025
The $31.56 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $63.87 · 2021: $84.01 · 2022: $146 · 2023: $218 · 2024: $5,257 · 2025: $31.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,235 · Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,235.44 |
| Food and Beverage | $271.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,267.00 | 2024-2025 | |
| Amgen INC. | $354.93 | 2022-2024 | Tezspire |
| Astrazeneca Pharmaceuticals LP | $276.57 | 2019-2023 | Tezspire |
| Sunovion Pharmaceuticals INC. | $127.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.62 | 2019 | |
| Glaxosmithkline, LLC. | $83.47 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $77.60 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $54.22 | 2019 | |
| Pfizer INC. | $53.40 | 2019 | |
| Shire North American Group INC | $38.94 | 2019 | |
| Grifols USA, LLC | $31.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.04 | 2019 | |
| Genzyme Corporation | $23.63 | 2021 | |
| Mylan Specialty L.P. | $19.73 | 2019 | |
| Insmed, INC. | $18.19 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.86 | 2019 | |
| Merck Sharp & Dohme LLC | $13.43 | 2019 | |
| Advanced Respiratory, INC | $13.19 | 2021 | |
| Philips North America LLC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hazen Tuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.